893 related articles for article (PubMed ID: 24127591)
1. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.
Parker SC; Stitzel ML; Taylor DL; Orozco JM; Erdos MR; Akiyama JA; van Bueren KL; Chines PS; Narisu N; ; Black BL; Visel A; Pennacchio LA; Collins FS; ;
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17921-6. PubMed ID: 24127591
[TBL] [Abstract][Full Text] [Related]
2. Genetic regulatory signatures underlying islet gene expression and type 2 diabetes.
Varshney A; Scott LJ; Welch RP; Erdos MR; Chines PS; Narisu N; Albanus RD; Orchard P; Wolford BN; Kursawe R; Vadlamudi S; Cannon ME; Didion JP; Hensley J; Kirilusha A; ; Bonnycastle LL; Taylor DL; Watanabe R; Mohlke KL; Boehnke M; Collins FS; Parker SC; Stitzel ML
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2301-2306. PubMed ID: 28193859
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants.
Pasquali L; Gaulton KJ; Rodríguez-Seguí SA; Mularoni L; Miguel-Escalada I; Akerman İ; Tena JJ; Morán I; Gómez-Marín C; van de Bunt M; Ponsa-Cobas J; Castro N; Nammo T; Cebola I; García-Hurtado J; Maestro MA; Pattou F; Piemonti L; Berney T; Gloyn AL; Ravassard P; Skarmeta JLG; Müller F; McCarthy MI; Ferrer J
Nat Genet; 2014 Feb; 46(2):136-143. PubMed ID: 24413736
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.
Wang X; Sterr M; Burtscher I; Chen S; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Cernilogar FM; Schotta G; Irmler M; Beckers J; Hrabě de Angelis M; Ray M; Wright CVE; Bakhti M; Lickert H
Mol Metab; 2018 Mar; 9():57-68. PubMed ID: 29396371
[TBL] [Abstract][Full Text] [Related]
5. In vitro scan for enhancers at the TCF7L2 locus.
Savic D; Park SY; Bailey KA; Bell GI; Nobrega MA
Diabetologia; 2013 Jan; 56(1):121-5. PubMed ID: 23011354
[TBL] [Abstract][Full Text] [Related]
6. Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes risk.
Chiou J; Zeng C; Cheng Z; Han JY; Schlichting M; Miller M; Mendez R; Huang S; Wang J; Sui Y; Deogaygay A; Okino ML; Qiu Y; Sun Y; Kudtarkar P; Fang R; Preissl S; Sander M; Gorkin DU; Gaulton KJ
Nat Genet; 2021 Apr; 53(4):455-466. PubMed ID: 33795864
[TBL] [Abstract][Full Text] [Related]
7. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers.
Khan A; Mathelier A; Zhang X
Epigenetics; 2018; 13(9):910-922. PubMed ID: 30169995
[TBL] [Abstract][Full Text] [Related]
8. Identification of biologically relevant enhancers in human erythroid cells.
Su MY; Steiner LA; Bogardus H; Mishra T; Schulz VP; Hardison RC; Gallagher PG
J Biol Chem; 2013 Mar; 288(12):8433-8444. PubMed ID: 23341446
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk.
Greenwald WW; Chiou J; Yan J; Qiu Y; Dai N; Wang A; Nariai N; Aylward A; Han JY; Kadakia N; Regue L; Okino ML; Drees F; Kramer D; Vinckier N; Minichiello L; Gorkin D; Avruch J; Frazer KA; Sander M; Ren B; Gaulton KJ
Nat Commun; 2019 May; 10(1):2078. PubMed ID: 31064983
[TBL] [Abstract][Full Text] [Related]
10. Identification of genomic enhancers through spatial integration of single-cell transcriptomics and epigenomics.
Bravo González-Blas C; Quan XJ; Duran-Romaña R; Taskiran II; Koldere D; Davie K; Christiaens V; Makhzami S; Hulselmans G; de Waegeneer M; Mauduit D; Poovathingal S; Aibar S; Aerts S
Mol Syst Biol; 2020 May; 16(5):e9438. PubMed ID: 32431014
[TBL] [Abstract][Full Text] [Related]
11. Genomic Characterization of Endothelial Enhancers Reveals a Multifunctional Role for NR2F2 in Regulation of Arteriovenous Gene Expression.
Sissaoui S; Yu J; Yan A; Li R; Yukselen O; Kucukural A; Zhu LJ; Lawson ND
Circ Res; 2020 Mar; 126(7):875-888. PubMed ID: 32065070
[TBL] [Abstract][Full Text] [Related]
12. A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression.
Kycia I; Wolford BN; Huyghe JR; Fuchsberger C; Vadlamudi S; Kursawe R; Welch RP; Albanus RD; Uyar A; Khetan S; Lawlor N; Bolisetty M; Mathur A; Kuusisto J; Laakso M; Ucar D; Mohlke KL; Boehnke M; Collins FS; Parker SCJ; Stitzel ML
Am J Hum Genet; 2018 Apr; 102(4):620-635. PubMed ID: 29625024
[TBL] [Abstract][Full Text] [Related]
13. Discovery of stimulation-responsive immune enhancers with CRISPR activation.
Simeonov DR; Gowen BG; Boontanrart M; Roth TL; Gagnon JD; Mumbach MR; Satpathy AT; Lee Y; Bray NL; Chan AY; Lituiev DS; Nguyen ML; Gate RE; Subramaniam M; Li Z; Woo JM; Mitros T; Ray GJ; Curie GL; Naddaf N; Chu JS; Ma H; Boyer E; Van Gool F; Huang H; Liu R; Tobin VR; Schumann K; Daly MJ; Farh KK; Ansel KM; Ye CJ; Greenleaf WJ; Anderson MS; Bluestone JA; Chang HY; Corn JE; Marson A
Nature; 2017 Sep; 549(7670):111-115. PubMed ID: 28854172
[TBL] [Abstract][Full Text] [Related]
14. The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program.
Kalna V; Yang Y; Peghaire CR; Frudd K; Hannah R; Shah AV; Osuna Almagro L; Boyle JJ; Göttgens B; Ferrer J; Randi AM; Birdsey GM
Circ Res; 2019 Apr; 124(9):1337-1349. PubMed ID: 30892142
[TBL] [Abstract][Full Text] [Related]
15. Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes.
Miguel-Escalada I; Bonàs-Guarch S; Cebola I; Ponsa-Cobas J; Mendieta-Esteban J; Atla G; Javierre BM; Rolando DMY; Farabella I; Morgan CC; García-Hurtado J; Beucher A; Morán I; Pasquali L; Ramos-Rodríguez M; Appel EVR; Linneberg A; Gjesing AP; Witte DR; Pedersen O; Grarup N; Ravassard P; Torrents D; Mercader JM; Piemonti L; Berney T; de Koning EJP; Kerr-Conte J; Pattou F; Fedko IO; Groop L; Prokopenko I; Hansen T; Marti-Renom MA; Fraser P; Ferrer J
Nat Genet; 2019 Jul; 51(7):1137-1148. PubMed ID: 31253982
[TBL] [Abstract][Full Text] [Related]
16. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.
Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A
BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627
[TBL] [Abstract][Full Text] [Related]
17. Cell Specificity of Human Regulatory Annotations and Their Genetic Effects on Gene Expression.
Varshney A; VanRenterghem H; Orchard P; Boyle AP; Stitzel ML; Ucar D; Parker SCJ
Genetics; 2019 Feb; 211(2):549-562. PubMed ID: 30593493
[TBL] [Abstract][Full Text] [Related]
18. An in vivo cis-regulatory screen at the type 2 diabetes associated TCF7L2 locus identifies multiple tissue-specific enhancers.
Savic D; Bell GI; Nobrega MA
PLoS One; 2012; 7(5):e36501. PubMed ID: 22590553
[TBL] [Abstract][Full Text] [Related]
19. Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease.
D'Aurizio R; Catona O; Pitasi M; Li YE; Ren B; Nicolis SK
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887306
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic and Transcriptomic Dynamics During Human Heart Organogenesis.
VanOudenhove J; Yankee TN; Wilderman A; Cotney J
Circ Res; 2020 Oct; 127(9):e184-e209. PubMed ID: 32772801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
